These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 34579238)

  • 1. Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward.
    Sobia P; Archary D
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioorganic approaches towards HIV vaccine design.
    Wang LX
    Curr Pharm Des; 2003; 9(22):1771-87. PubMed ID: 12871196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines.
    Koff WC; Russell ND; Walport M; Feinberg MB; Shiver JW; Karim SA; Walker BD; McGlynn MG; Nweneka CV; Nabel GJ
    Vaccine; 2013 Apr; 31 Suppl 2():B204-8. PubMed ID: 23598483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS Vaccine Research Subcommittee (AVRS) Consultation: Early-Life Immunization Strategies against HIV Acquisition.
    Singh A; Permar S; Kollmann TR; Levy O; Marovich M; De Paris K
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31315966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of vaccine research and development of vaccines for HIV-1.
    Safrit JT; Fast PE; Gieber L; Kuipers H; Dean HJ; Koff WC
    Vaccine; 2016 Jun; 34(26):2921-2925. PubMed ID: 26993335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on mucosal HIV vaccine vectors.
    Duerr A
    Curr Opin HIV AIDS; 2010 Sep; 5(5):397-403. PubMed ID: 20978380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current advances and challenges in HIV-1 vaccines.
    Rodriguez-Chavez IR; Allen M; Hill EL; Sheets RL; Pensiero M; Bradac JA; D'Souza MP
    Curr HIV/AIDS Rep; 2006 Feb; 3(1):39-47. PubMed ID: 16522258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A safe, effective and affordable HIV vaccine--an urgent global need.
    Joseph J; Etcheverry F; Alcami J; María GJ
    AIDS Rev; 2005; 7(3):131-8. PubMed ID: 16302460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hunt for the AIDS vaccine.
    Essex M
    AIDS Asia; 1995; 2(3):10-3. PubMed ID: 12319586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem.
    Koff WC
    Vaccine; 2012 Jun; 30(29):4310-5. PubMed ID: 22100891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV vaccine development: lessons from the past and promise for the future.
    Spearman P
    Curr HIV Res; 2003 Jan; 1(1):101-20. PubMed ID: 15043215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV vaccination: Navigating the path to a transformative breakthrough-A review of current evidence.
    Scott GY; Worku D
    Health Sci Rep; 2024 Sep; 7(9):e70089. PubMed ID: 39319247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current views on the potential for development of a HIV vaccine.
    Cohen KW; Frahm N
    Expert Opin Biol Ther; 2017 Mar; 17(3):295-303. PubMed ID: 28095712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in immune-based interventions to prevent HIV-1 transmission to children.
    Voronin Y; Jani I; Graham BS; Cunningham CK; Mofenson LM; Musoke PM; Permar SR; Scarlatti G
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29282882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is an HIV vaccine possible?
    Wilson NA; Watkins DI
    Braz J Infect Dis; 2009 Aug; 13(4):304-10. PubMed ID: 20231996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collection and processing of mucosal secretions from mice.
    Kaminski RW; Vancott TC
    Methods Mol Med; 1999; 17():329-39. PubMed ID: 21380685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological mechanisms of inducing HIV immunity in infants.
    Fouda GG; De Paris K; Levy O; Marchant A; Gray G; Permar S; Marovich M; Singh A
    Vaccine; 2020 Jan; 38(3):411-415. PubMed ID: 31761501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.